Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AbbVie, AcelRx, aid, alleviating, Alnylam, ALZA, analgesic, antagonist, antibacterial, antibody, antifungal, ascending, ASIC, bad, Bank, banking, Basel, benchmarking, bioavailability, bioavailablity, BMS, borrowing, bovine, BPCIA, burn, button, Cadence, California, Cambridge, cap, CareFusion, carved, cattle, cautery, CDER, cellulose, center, codified, collagen, compact, condensed, consumption, Conversely, conversion, convertase, CSL, Curlin, dedicated, deducting, device, dictate, diffuse, disadvantage, disagreement, discretionary, dispensing, dissolved, DNA, domain, DPT, earliest, electric, electronic, embedded, enzyme, escrow, Ethicon, evithrom, excision, exempt, explaining, extra, Factor, Fargo, fast, faster, FDASIA, feature, fentanyl, fibrin, fibrinogen, flowable, fractional, fundamental, gelatin, gelfoam, gene, grace, granular, greatest, gut, hand, hemostat, hemostatic, hepatic, Hong, hour, hydrochloride, hypercholesterolemia, Imagery, immunogenicity, impractical, Incline, incurrence, indenture, ineffective, inheritance, insignificant, installment, intubated, IONSYSTM, iontophoretic, junior, kexin, kit, Kong, labor, LDL, leave, ligation, link, LP, lyophilized, manuscript, microbiologically, mid, mild, mobility, NanoTab, nausea, neurosurgical, noncontrolling, OCP, oozing, opioid, orthopedic, pad, palliation, par, partly, passive, pathogen, PCA, perception, peri, physically, plastic, postoperative, powder, preceding, premarket, problematic, proposition, proprotein, prosthetic, pulse, pump, purification, putty, QIDP, QTcF, qualification, rank, rationale, ready, recombinant, reconstituted, recothrom, recovery, redeem, Redwood, refinancing, reinstated, reorganization, repay, repayment, repolarization, resection, rest, retroactively, risky, RNA, RNAi, roughly, saline, Sanmina, Saxony, sealant, Seattle, Semiconductor, Session, silencing, Silver, spinal, split, sponge, spray, sprayed, steering, sterile, stored, strength, stronger, subcutaneously, subordinated, subtilisin, sufentanil, supratherapeutic, surface, Surfer, surgeon, survive, tablet, temperature, thousand, TM, top, tradename, transdermal, transdermally, trauma, trustee, twelfth, uniform, unknown, unpaid, unremitted, unsecured, unwinding, usability, user, verification, vulnerability, wound, XIII
Removed:
abandonment, accumulate, acutely, aprotinin, arose, award, bankrupt, Barr, Bayer, brain, Canadian, cardiopulmonary, combat, comparison, compelling, complaint, consolidate, controlling, delist, died, disagree, dysfunction, easy, ECLIPSE, eliminating, ESCAPE, expending, forecast, forma, formal, foundation, frequently, guide, hemorrhage, indemnify, initiating, insolvent, intentional, intracerebral, invasive, licenseable, machine, main, median, metabolized, Milano, misinterpreted, modern, monotherapy, mortality, muscle, negligence, newer, nicardipine, nitroglycerine, nitroprusside, nonfinancial, oldest, overshoot, Parenteral, perpetual, precise, prescribing, prophylactic, provisional, quadruple, reconsideration, registry, reinfarction, relaxing, renal, rendered, respond, retrospective, routine, save, SCCM, selective, septic, simplified, smooth, Society, sodium, SPRINT, stay, stream, strive, studied, subgroup, sublicenseable, subset, suited, surveyed, switching, titration, Trasylol, triple, true, understand, underwent, unsold, vacate, VELOCITY, vessel, weighting, wide, widening, withdrawn, write, wrongful
Filing tables
Filing exhibits
Related press release
MDCO similar filings
Filing view
External links
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Forms S-8 No. 333-44884, 333-74612, 333-98191, 333-116295, 333-135460, 333-135461, 333-148602, 333-152105, 333-157499, 333-161672, 333-167895, 333-167896) pertaining to the 1998 Stock Incentive Plan, the 2000 Outside Director Stock Option Plan, the 2000 Employee Stock Purchase Plan, the 2001 Non-Officer, Non-Director Employee Stock Incentive Plan, the 2004 Stock Incentive Plan, the 2007 Equity Inducement Plan, the 2009 Equity Inducement Plan, the Amended and Restated 2004 Stock Incentive Plan, and the 2010 Employee Stock Purchase Plan of The Medicines Company and Registration Statement (Form S-3 No. 333-139987) of our reports dated March 1, 2013 with respect to the consolidated financial statements of The Medicines Company and the effectiveness of internal control over financial reporting of The Medicines Company included in this Annual Report (Form 10-K) for the year ended December 31, 2012.
/s/ Ernst & Young LLP
MetroPark, New Jersey
March 1, 2013